Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 7/20 | 1.00 |
| ▸ | MAPT | P10636 | 6/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 2/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 2/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 2/20 | 1.00 |
| ▸ | TBXA2R | P21731 | 2/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 2/20 | 1.00 |
| ▸ | APEX1 | P27695 | 2/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 2/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 2/20 | 1.00 |
| ▸ | OPRM1 | P35372 | 2/20 | 1.00 |
| ▸ | DRD3 | P35462 | 2/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 1.00 |
| ▸ | MAOA | P21397 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
| ▸ | RAD52 | P43351 | 3/20 | 0.77 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lucanthone SCHEMBL29422254 | 1.00 | APP (1.00) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL30572937 | 1.00 | APP (1.00) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL29503548 | 0.99 | APP (0.98) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL419165 | 0.99 | APP (0.98) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL8004521 | 0.99 | APP (0.98) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL28172520 | 0.99 | APP (0.98) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL1650327 | 0.98 | APP (0.96) | APPMAPTCHRM2HTR1AADRA2A | |
| Lucanthone SCHEMBL7517404 | 0.95 | APP (0.90) | APPMAPTCHRM2HTR1AADRA2A | |
| SCHEMBL13856933 | 0.93 | APP (0.86) | APPMAPTCHRM2HTR1AADRA2A | |
| Becanthone SCHEMBL1641785 | 0.91 | APP (0.83) | APPMAPTCHRM2HTR1AADRA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6097 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137806-A1 | INTERCALATING SUGAR MOLECULES | XALUD THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | US | claimed |
| US-20260085061-A1 | PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS | SITRYX THERAPEUTICS LIMITED (GB) | 2026-03-26 | — | — | US | claimed |
| US-12577255-B2 | MDM2-based modulators of proteolysis and associated methods of use | ARVINAS OPERATIONS, INC. (US) | 2026-03-17 | — | — | US | claimed |
| EP-4704832-A2 | BIFUNCTIONAL SMALL MOLECULES TO TARGET THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS | Biohaven Therapeutics Ltd. (VG) | 2026-03-11 | — | — | EP | claimed |
| US-20260022117-A1 | COMPOUNDS AND METHODS FOR THE ENHANCED DEGRADATION OF TARGETED PROTEINS | ARVINAS OPERATIONS INC (US) | 2026-01-22 | — | — | US | claimed |
| US-12485178-B2 | Bifunctional small molecules to target the selective degradation of circulating proteins | YALE UNIVERSITY (US) | 2025-12-02 | — | — | US | claimed |
| US-20250332274-A1 | BIFUNCTIONAL SMALL MOLECULES TO TARGET THE SELECTIVE DEGRADATION OF CIRCULATING PROTEINS | UNIV YALE (US) | 2025-10-30 | — | — | US | claimed |
| US-20250295629-A1 | COMPOSITIONS AND METHODS FOR TREATING CANCERS OF THE CENTRAL NERVOUS SYSTEM (CNS), INCLUDING GLIOBLASTOMA AND CHEMORESISTANT CNS TUMORS, AND RELATED COMPOSITIONS AND METHODS FOR INHIBITING AND ELIMINATING CNS CANCER STEM CELLS | RADIN DANIEL PIERCE (US) | 2025-09-25 | — | — | US | claimed |
| EP-4612132-A1 | PHTHALAZINE DERIVATIVES AS PYRUVATE KINASE MODULATORS | Sitryx Therapeutics Limited (GB) | 2025-09-10 | — | — | EP | claimed |
| EP-4586826-A1 | FEED AND METHODS FOR CONTROLLING HEARTWORM INFECTIONS IN A MAMMAL | In the Bowl Animal Health, Inc. (US) | 2025-07-23 | — | — | EP | claimed |
| WO-2000050031-A9 | CO-ADMINISTRATION OF LUCANTHONE AND RADIATION FOR TREATMENT OF CANCER | BASES ROBERT (US) | 2002-06-20 | — | — | WO | claimed |
| US-6391911-B1 | Coadministration of lucanthone and radiation for treatment of cancer | BASES ROBERT E (US) | 2002-05-21 | — | — | US | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000050031-A1 | CO-ADMINISTRATION OF LUCANTHONE AND RADIATION FOR TREATMENT OF CANCER | BASES ROBERT (US) | 2000-08-31 | — | — | WO | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| EP-0507629-B1 | Sustained release capsule and formulations for insertion into rumen | LILLY CO ELI (US) | 1997-01-22 | — | — | EP | claimed |
| US-5277912-A | Sustained release capsule and formulations | ELI LILLY AND COMPANY (US) | 1994-01-11 | — | — | US | claimed |
| CN-1067810-A | Sustained-release capsule and preparation | LILLY CO ELI (US) | 1993-01-13 | — | — | CN | claimed |
| EP-0507629-A1 | Sustained release capsule and formulations for insertion into rumen | ELI LILLY AND COMPANY (US) | 1992-10-07 | — | — | EP | claimed |